These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27023610)

  • 1. NORE1A Regulates MDM2 Via β-TrCP.
    Schmidt ML; Calvisi DF; Clark GJ
    Cancers (Basel); 2016 Mar; 8(4):. PubMed ID: 27023610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
    Schmidt ML; Donninger H; Clark GJ
    J Biol Chem; 2014 Nov; 289(45):31102-10. PubMed ID: 25217643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras Regulates Rb via NORE1A.
    Barnoud T; Donninger H; Clark GJ
    J Biol Chem; 2016 Feb; 291(6):3114-23. PubMed ID: 26677227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NORE1A is a double barreled Ras senescence effector that activates p53 and Rb.
    Donninger H; Barnoud T; Clark GJ
    Cell Cycle; 2016 Sep; 15(17):2263-4. PubMed ID: 26919075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
    Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
    Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
    Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
    J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and NORE1A Form a Her2/Ras Regulated Tumor Suppressor Complex Modulating Senescence.
    Nelson N; Jigo R; Clark GJ
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCF
    Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
    Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein and ubiquitin ligase MDM2.
    Liu J; Zou X; Gotoh T; Brown AM; Jiang L; Wisdom EL; Kim JK; Finkielstein CV
    Sci Signal; 2018 Nov; 11(556):. PubMed ID: 30425162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.
    Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekström TJ; Farnebo F; Larsson C
    Int J Cancer; 2008 Jul; 123(2):389-394. PubMed ID: 18452173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.
    Inuzuka H; Tseng A; Gao D; Zhai B; Zhang Q; Shaik S; Wan L; Ang XL; Mock C; Yin H; Stommel JM; Gygi S; Lahav G; Asara J; Xiao ZX; Kaelin WG; Harper JW; Wei W
    Cancer Cell; 2010 Aug; 18(2):147-59. PubMed ID: 20708156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.
    Hesson L; Dallol A; Minna JD; Maher ER; Latif F
    Oncogene; 2003 Feb; 22(6):947-54. PubMed ID: 12584574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras signaling through RASSF proteins.
    Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
    Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
    Singh A; Erijman A; Noronha A; Kumar H; Peleg Y; Yarden Y; Shifman JM
    J Biol Chem; 2021 Dec; 297(6):101353. PubMed ID: 34717958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
    Stieglitz B; Bee C; Schwarz D; Yildiz O; Moshnikova A; Khokhlatchev A; Herrmann C
    EMBO J; 2008 Jul; 27(14):1995-2005. PubMed ID: 18596699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.
    Foukakis T; Au AY; Wallin G; Geli J; Forsberg L; Clifton-Bligh R; Robinson BG; Lui WO; Zedenius J; Larsson C
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1143-9. PubMed ID: 16352687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.